Director/PDMR Shareholding

RNS Number : 2025T

Haleon PLC

20 July 2022

 

HALEON PLC  

  Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them  

20 July 2022  

Notification and Public Disclosure in accordance with the requirements of The EU Market Abuse Regulation of Transactions by Persons Discharging Managerial Responsibilities ("PDMR") and Persons Closely Associated with them. 

On 18 July 2022, Haleon plc (the "Company") received notification of the following transaction as detailed below . 

1	Details of the person discharging managerial responsibilities / person closely associated
a)	Name	Brian McNamara
2	Reason for the notification
a)	Position/status	Chief Executive Officer - Person Discharging Managerial Responsibilities
b)	Initial notification /Amendment	Initial Notification
3	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	Haleon plc
b)	LEI	549300PSB3WWEODCUP19
4	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument, type of instrument	Haleon plc American Depositary Shares (ADS)
	Identification code	US405552100
b)	Nature of the transaction	ADSs received in the Company on 18 July 2022, in accordance with the terms of the demerger from GSK as disclosed in the Company's prospectus dated 1 June 2022.
c)	Price(s) and volume(s)
			Price(s)	Volume(s)
			n/a	121,929
d)	Aggregated information
	- Aggregated volume	121,929
	- Price	n/a
e)	Date of the transaction	18 July 2022
f)	Place of the transaction	New York Stock Exchange

1	Details of the person discharging managerial responsibilities / person closely associated
a)	Name	Amy Landucci
2	Reason for the notification
a)	Position/status	Chief Digital and Technology Officer - Person Discharging Managerial Responsibilities
b)	Initial notification /Amendment	Initial Notification
3	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	Haleon plc
b)	LEI	549300PSB3WWEODCUP19
4	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument, type of instrument	Haleon plc American Depositary Shares (ADS)
	Identification code	US405552100
b)	Nature of the transaction	ADSs received in the Company on 18 July 2022, in accordance with the terms of the demerger from GSK as disclosed in the Company's prospectus dated 1 June 2022.
c)	Price(s) and volume(s)
			Price(s)	Volume(s)
			n/a	5,681
d)	Aggregated information
	- Aggregated volume	5,681
	- Price	n/a
e)	Date of the transaction	18 July 2022
f)	Place of the transaction	New York Stock Exchange

1	Details of the person discharging managerial responsibilities / person closely associated
a)	Name	Teri Lyng
2	Reason for the notification
a)	Position/status	Head of Transformation and Sustainability - Person Discharging Managerial Responsibilities
b)	Initial notification /Amendment	Initial Notification
3	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	Haleon plc
b)	LEI	549300PSB3WWEODCUP19
4	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument, type of instrument	Haleon plc American Depositary Shares (ADS)
	Identification code	US405552100
b)	Nature of the transaction	ADSs received in the Company on 18 July 2022, in accordance with the terms of the demerger from GSK as disclosed in the Company's prospectus dated 1 June 2022.
c)	Price(s) and volume(s)
			Price(s)	Volume(s)
			n/a	19,049
d)	Aggregated information
	- Aggregated volume	19,049
	- Price	n/a
e)	Date of the transaction	18 July 2022
f)	Place of the transaction	New York Stock Exchange

1	Details of the person discharging managerial responsibilities / person closely associated
a)	Name	Lisa Paley
2	Reason for the notification
a)	Position/status	President, North America - Person Discharging Managerial Responsibilities
b)	Initial notification /Amendment	Initial Notification
3	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	Haleon plc
b)	LEI	549300PSB3WWEODCUP19
4	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument, type of instrument	Haleon plc American Depositary Shares (ADS)
	Identification code	US405552100
b)	Nature of the transaction	ADSs received in the Company on 18 July 2022, in accordance with the terms of the demerger from GSK as disclosed in the Company's prospectus dated 1 June 2022.
c)	Price(s) and volume(s)
			Price(s)	Volume(s)
			n/a	7,126
d)	Aggregated information
	- Aggregated volume	7,126
	- Price	n/a
e)	Date of the transaction	18 July 2022
f)	Place of the transaction	New York Stock Exchange

Amanda Mellor  

Company Secretary  

 

END

 

 

DSHBLGDRIBDDGDG